IP Library Granted Patent US 10,369,251
Granted Patent B2
US 10,369,251 · App. 15/162,657 · Granted Aug 6, 2019

Anti-microbial and osteointegration nanotextured surfaces

Inventors: Jeffrey Tyber (Breiningsville, PA); Rui J. Ferreira (Livingston, NJ); Chris Faresich (Easton, PA)
Assignee: Tyber Medical, LLC
A61L27/04A61B17/8095A61B90/94A61F2/28A61F2/447A61F2/4455A61F2/4465A61F2/4603A61F2/4611A61L27/025A61L27/306A61B17/7059A61B17/8645A61B2090/037A61F2/30771A61F2002/2817A61F2002/2835A61F2002/3008A61F2002/30013A61F2002/30029A61F2002/3082A61F2002/3092A61F2002/3093A61F2002/30266A61F2002/30281A61F2002/30321A61F2002/30326A61F2002/30355A61F2002/30509A61F2002/30578A61F2002/30714A61F2002/30774A61F2002/30808A61F2002/30836A61F2002/30843A61F2002/4475A61F2002/4623A61F2002/4627A61F2310/00407A61F2310/00461A61F2310/00796A61L2400/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,369,251
App. No.
15/162,657
Granted
Aug 6, 2019
Kind
B2
Abstract

Disclosed is a medical device having a substrate having an exposed surface and a texture over at least part of the exposed surface. The texture includes a plurality of nanofeatures that inhibit bacterial adhesion on the surface and that also inhibit bacterial growth on the surface and have a size range between about 0.01 nanometers and about 1,000 nanometers. The texture can include a plurality of nanofeatures applied thereto such that the texture has a first particle size at a first location, a second particle size at a second location, and a gradient of particle size from the first particle size to the second particle size between the first location and the second location.

Claims (13)

1. A medical device comprising:

a substrate having an exposed surface; and

a texture over at least part of the exposed surface, the texture comprising a plurality of nanofeatures, the nanofeatures having a first size range over a first portion of the exposed surface that produces a first property and a second size range, different from the first size range, over a second portion of the exposed surface that produces a second property, different from the first property.

2. The medical device according to claim 1 , wherein the first property inhibits bacterial adhesion on the surface.

3. The medical device according to claim 2 , wherein the first range is between about 0.01 nanometers and about 1,000 nanometers.

4. The medical device according to claim 2 , wherein the second property enhances osteointegration of the texture.

5. The medical device according to claim 4 , wherein the second range is between about 15 nanometers and about 3 millimeters.

6. A medical device comprising:

a substrate having an exposed surface; and

a texture over at least part of the exposed surface, the texture comprising a plurality of nanofeatures applied to the exposed surface, the texture having a only first particle size at a first region, a second particle size, different from the first particle size, at a second region, and a gradient of particle size from the first particle size to the second particle size between the first region and the second region.

7. The medical device according to claim 6 , wherein the nanofeatures at the first region have a first shape, and wherein the nanofeatures at the second region have a second shape, different from the first shape.

8. The medical device according to claim 6 , wherein the nanofeatures at the first region have a first size range and wherein the nanofeatures at the second region have a second size range, different from the first size range.

9. The medical device according to claim 6 , wherein the first particle size is sized to enhance osteoconductivity and wherein the second particle size is sized to enhance anti-bacterial properties.

Assignments (3)
SECURITY INTEREST Recorded Jun 12, 2025
From: PIONEER SURGICAL TECHNOLOGY, INC.; TYBER MEDICAL LLC; SMADE SAS; BRADSHAW MEDICAL INC.; TURNER MEDICAL, INC.; IN’TECH MEDICAL SAS
To: OHA AGENCY LLC, AS COLLATERAL AGENT
Reel/Frame 071575/0563 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2024
From: TYBER, JEFFREY; FERREIRA, RUI; FARESICH, CHRISTOPHER
To: TYBER MEDICAL LLC
Reel/Frame 068102/0727 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2017
From: TYBER, JEFFREY; FERREIRA, RUI; FARESICH, CHRISTOPHER
To: TYBER MEDICAL, LLC
Reel/Frame 041174/0388 →
Continuity (5)
Continuation In Part 14948322 · Nov 22, 2015
Continuation In Part 14513300 · Oct 14, 2014
Continuation In Part 14054100 · Oct 15, 2013
Provisional Application 61715891 · Oct 19, 2012
Related Publication 20160263276A1 · Sep 15, 2016